MtInhA-IN-1 is a potent, selective, and orally active inhibitor targeting the Mycobacterium tuberculosis NADH-dependent enoyl-acyl carrier protein reductase (MtInhA), demonstrating an IC50 of 0.23 µM. It exhibits strong efficacy against the M. tuberculosis H37Rv strain, with a MIC value of 0.4 µM.
Molecular Weight:
396.32
Formula:
C21H22BrN3
Target:
Others|||Antibacterial
T73032
* VAT and and shipping costs not included. Errors and price changes excepted
